Ribosomopathies: New Therapeutic Perspectives.

Orgebin E, Lamoureux F, Isidor B, Charrier C, Ory B, Lézot F, Baud'huin M

DOI: 10.3390/cells9092080
Published: 2020 Sep 11
Container: Cells
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cells9092080,
  title = {Ribosomopathies: New Therapeutic Perspectives.},
  author = {Orgebin E and Lamoureux F and Isidor B and Charrier C and Ory B and Lézot F and Baud'huin M},
  year = {2020},
  journal = {Cells},
  doi = {10.3390/cells9092080},
  url = {https://doi.org/10.3390/cells9092080}
}

RIS

TY  - JOUR
TI  - Ribosomopathies: New Therapeutic Perspectives.
AU  - Orgebin E
AU  - Lamoureux F
AU  - Isidor B
AU  - Charrier C
AU  - Ory B
AU  - Lézot F
AU  - Baud'huin M
PY  - 2020
JO  - Cells
DO  - 10.3390/cells9092080
UR  - https://doi.org/10.3390/cells9092080
ER  -

APA

E, O., F, L., B, I., C, C., B, O., F, L., & M, B. (2020). Ribosomopathies: New Therapeutic Perspectives.. Cells. https://doi.org/10.3390/cells9092080

Source records

pubmed · retrieved 2026-11-10T14:21:13.740Z